.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Cerilliant
Farmers Insurance
Chubb
QuintilesIMS
AstraZeneca
Queensland Health
US Army
Covington
Colorcon

Generated: June 26, 2017

DrugPatentWatch Database Preview

ETHMOZINE Drug Profile

« Back to Dashboard

What is the patent landscape for Ethmozine, and what generic Ethmozine alternatives are available?

Ethmozine is a drug marketed by Shire and is included in one NDA.

The generic ingredient in ETHMOZINE is moricizine hydrochloride. Additional details are available on the moricizine hydrochloride profile page.

Summary for Tradename: ETHMOZINE

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list51
Clinical Trials: see list2
Patent Applications: see list159
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ETHMOZINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire
ETHMOZINE
moricizine hydrochloride
TABLET;ORAL019753-001Jun 19, 1990DISCNNoNo► Subscribe► Subscribe
Shire
ETHMOZINE
moricizine hydrochloride
TABLET;ORAL019753-002Jun 19, 1990DISCNNoNo► Subscribe► Subscribe
Shire
ETHMOZINE
moricizine hydrochloride
TABLET;ORAL019753-003Jun 19, 1990DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ETHMOZINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Shire
ETHMOZINE
moricizine hydrochloride
TABLET;ORAL019753-002Jun 19, 19903,864,487► Subscribe
Shire
ETHMOZINE
moricizine hydrochloride
TABLET;ORAL019753-003Jun 19, 19903,864,487► Subscribe
Shire
ETHMOZINE
moricizine hydrochloride
TABLET;ORAL019753-001Jun 19, 19903,740,395► Subscribe
Shire
ETHMOZINE
moricizine hydrochloride
TABLET;ORAL019753-002Jun 19, 19903,740,395► Subscribe
Shire
ETHMOZINE
moricizine hydrochloride
TABLET;ORAL019753-003Jun 19, 19903,740,395► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Medtronic
Mallinckrodt
Harvard Business School
Chinese Patent Office
McKinsey
Daiichi Sankyo
Fuji
Deloitte
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot